Type-I IFN
[대역어] 타입 I IFN
[용어속성] Term
[용어속성] Term
Retinol Depletion in COVID-19
Research article
[키워드] age
AIDS
Comorbidity
control group
COVID-19
COVID-19 group
COVID-19 pathogenesis
Depletion
Gender
Hospitalized
Immune homeostasis
Immunopathogenesis
independent
indication
infections
intensive care
no significant difference
not affect
pandemic
Patient
patients without COVID-19
Respiratory failure
Result
retinoic acid
retinol
RSV
SARS-CoV2
serum
severe COVID-19
severe COVID-19 patient
Signaling
significantly lower
statistically significant
Symptoms
two group
Type-I IFN
Vitamin
vitamin A
was measured
[DOI] 10.1016/j.nutos.2022.05.007 [Article Type] Research article
[DOI] 10.1016/j.nutos.2022.05.007 [Article Type] Research article
A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder
Article
[키워드] Akt, serine/threonine specific protein kinase B
ATRA, All-trans retinoic acid
Autoimmunity
BALF, bronchoalveolar lavage fluid
c-Myc, cellular Myc proto-oncogene
CDC, Centers for Disease Control and Prevention
cisRA, cis isomers of retinoic acid
COVID-19
COVID-19, Coronavirus disease 2019
CRABP-1, cytoplasmic retinoic acid binding protein 1
CRBP-I, cytoplasmic retinol binding protein 1
CXCL9, C-X-C motif chemokine ligand 9
CYP26, cytochrome P450 family 26
CYP27, cytochrome P450 family 27
CYP450
CYP450, cytochrome P450 superfamily of enzymes
Erk, extracellular-signal-regulated kinase
FOXP3
FoxP3, Forkhead box P3 transcription factor
GluR1, glutamate receptor 1
IFN, interferon
IL, interleukin cytokines
IL2RA, interleukin 2 receptor-alpha subunit
Inflammation
IRF, interferon-regulatory factors
JAK, Janus kinases
Lyn, Lyn protein kinase, a member of Src family tyrosine kinases
MAPK, Mitogen-activated protein kinase
MDA5, Melanoma differentiation-associated protein 5
NCoA, nuclear receptor co-activators
NCoR, nuclear receptor co-repressors
NF-κB
NF-κB, nuclear factor kappa light chain enhancer of activated B cells
PI3K, Phosphatidylinositol-3-kinase
PPAR, Peroxisome proliferator-activated receptor
PRR, Pattern Recognition Receptors
RA, retinoic acid
RALDH, retinaldehyde dehydrogenase enzyme
RAR, retinoic acid receptors
RARE, retinoic acid response elements (regulatory DNA sequences bound by retinoic acid receptors)
RBP, retinol binding protein
RDH, retinol dehydrogenase enzymes
retinoic acid
Retinoid signaling
retinol
RIG-I
RIG-I, retinoic acid-inducible gene-I
RLR, RIG-I-like receptor
RORγt
RORγt, Retinoic acid-related orphan receptor gT transcription factor
RXR, retinoid X receptors
SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2
sST2, soluble suppression of tumorigenicity 2
STAT, Signal transducer and activator of transcription
sTNFRSF1A, soluble TNF receptor superfamily member 1A
STRA6, signaling receptor and transporter of retinol
TGF-β, Transforming growth factor-beta
Th17
Th17, T helper 17 cells
TLR, toll-like receptors
TNF, Tumor Necrosis Factor
TRAF, TNF receptor (TNF-R)-associated factor
Treg
Treg, regulatory T cells
Type-I IFN
Type-I IFN, Type I interferon (IFN-α and IFN-β)
VAD, vitamin A deficiency
VitA, vitamin A
vitamin A
Vitamin D
VitD, vitamin D
WHO, World Health Organization
[DOI] 10.1016/j.cellsig.2021.110121 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.cellsig.2021.110121 PMC 바로가기 [Article Type] Article
Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome
급성 호흡 곤란 증후군이 있는 중환자 COVID-19 환자의 IFN-I 활성 및 면역 프로파일에 대한 종단 평가
Clinical Trial
[키워드] acute respiratory distress
acute respiratory distress syndrome
alteration
appear
ARDS
ARDS patient
ARDS patients
Bacterial sepsis
cellular
COVID-19
COVID-19 patient
COVID-19 patients
Critically ill
critically ill COVID-19 patients
Critically ill patient
critically ill patients
cytokine
cytokine levels
Cytokines
decrease
described
Elevation
expression
followed by
Hospital stay
ICU admission
IFN response
IFN-I
IFN-stimulated gene
IFN-stimulated genes
IFNα2
immune
immune parameter
Immune profile
immune response
immune responses
immuno-inflammatory
Immunosuppression
intensity
ISG
longitudinal
longitudinal immune monitoring
lymphocyte
Lymphocyte count
marker
mHLA-DR
non-survivor
normal values
Occurrence
outcome
pandemic
plasma
question
respiratory distress
Result
SARS-CoV2 infection
Secondary infection
secondary infections
Sepsis
similarities
similarity
supplementary material
Survivors
syndrome
TNF-α
Type-I IFN
[DOI] 10.1186/s13054-021-03558-w PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1186/s13054-021-03558-w PMC 바로가기 [Article Type] Clinical Trial